UCLA research highlights delayed Huntington’s disease diagnosis for Black patients

FHS
July 10, 2024
3:56 am

New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.

Legal Battles and Investor Concerns: FSD Pharma’s Rocky Road | Psychedelic Invest

FSD Pharma, a Canadian pharmaceutical company, has found itself in the midst of several ongoing legal battles, raising doubts about the strength of this psychedelic

July 13, 2023

Physically active women less likely to develop breast cancer before menopause

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now.

December 15, 2023

Pharmalittle: We’re reading about FTC fighting ‘junk’ patents, Pfizer direct-to-consumer plans, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.